Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
KRAS mutation: from undruggable to druggable in cancer
L Huang, Z Guo, F Wang, L Fu - Signal transduction and targeted …, 2021 - nature.com
Cancer is the leading cause of death worldwide, and its treatment and outcomes have been
dramatically revolutionised by targeted therapies. As the most frequently mutated oncogene …
dramatically revolutionised by targeted therapies. As the most frequently mutated oncogene …
The role of wild-type RAS in oncogenic RAS transformation
E Sheffels, RL Kortum - Genes, 2021 - mdpi.com
The RAS family of oncogenes (HRAS, NRAS, and KRAS) are among the most frequently
mutated protein families in cancers. RAS-mutated tumors were originally thought to …
mutated protein families in cancers. RAS-mutated tumors were originally thought to …
Pancreatic organoids: a frontier method for investigating pancreatic-related diseases
Y Liu, N Li, Y Zhu - International Journal of Molecular Sciences, 2023 - mdpi.com
The pancreas represents an important organ that has not been comprehensively studied in
many fields. To fill this gap, many models have been generated, and traditional models have …
many fields. To fill this gap, many models have been generated, and traditional models have …
[HTML][HTML] Autophagy inhibition in BRAF-driven cancers
Simple Summary BRAF is a protein kinase that is frequently mutationally activated in cancer.
Mutant BRAF can be pharmacologically inhibited, which in combination with blockade of its …
Mutant BRAF can be pharmacologically inhibited, which in combination with blockade of its …
[HTML][HTML] Proteomic map** of the interactome of KRAS mutants identifies new features of RAS signalling networks and the mechanism of action of sotorasib
Simple Summary Cancer is caused by changes in DNA called mutations that alter the way
proteins work. We know that RAS proteins are one of the most commonly mutated proteins in …
proteins work. We know that RAS proteins are one of the most commonly mutated proteins in …
Clinicopathological Characteristics and Mutational Landscape of APC, HOXB13, and KRAS among Rwandan Patients with Colorectal Cancer
F Manirakiza, E Rutaganda, H Yamada… - Current Issues in …, 2023 - mdpi.com
Cancer research in Rwanda is estimated to be less than 1% of the total African cancer
research output with limited research on colorectal cancer (CRC). Rwandan patients with …
research output with limited research on colorectal cancer (CRC). Rwandan patients with …